Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

835
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
835
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

749
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
749
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

591
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
591
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

2.0K
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
2.0K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

515
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
515
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

596
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
596

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical significance of ADAMTS1, ADAMTS5, ADAMTS9 aggrecanases and IL-17A, IL-23, IL-33 cytokines in polycystic ovary syndrome.

Journal of endocrinological investigation·2016
Same author

Fibromyalgia and its clinical relevance in renal transplant recipients.

Transplantation proceedings·2015
Same author

Sagittal abdominal diameter as an anthropometric measure of cardiovascular and graft loss risk in renal transplant recipients.

Transplantation proceedings·2015
Same author

Hyperviscosity in renal transplant recipients.

Transplantation proceedings·2015
Same author

High-grade proteinuria as a cardiovascular risk factor in renal transplant recipients.

Transplantation proceedings·2015
Same author

Post-transplant C-reactive protein predicts arterial stiffness and graft function in renal transplant recipients.

Transplantation proceedings·2015
Same journal

Analysis of the Cost of Maintaining Effective Donors and Nondonors of Organs and Tissues in Intensive Care Units.

Transplantation proceedings·2026
Same journal

Adolescence and Pediatric Heart Transplantation: Impact of Non-Adherence on Mortality: A Single-Center Experience.

Transplantation proceedings·2026
Same journal

Impact of Family-Based Care on the Outcome of Brain Death and Humanization in the Process of Multiple Organ Donation: Case Report.

Transplantation proceedings·2026
Same journal

Karnofsky Performance Status Is Associated with Patient and Graft Survival After Liver Retransplantation.

Transplantation proceedings·2026
Same journal

Evaluating CMV Risk Stratification, Donor Characteristics, and Post-Transplant Outcomes in Kidney Transplant Recipients: A Retrospective Eurotransplant Center Analysis.

Transplantation proceedings·2026
Same journal

Twenty-One Years of Insights From A Single-Center Living Kidney Donation Program.

Transplantation proceedings·2026
See all related articles

Related Experiment Video

Updated: Apr 11, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

22.5K

Post-transplant Hyperuricemıa as a Cardıovascular Risk Factor.

M Erkmen Uyar1, S Sezer1, Z Bal1

  • 1Department of Nephrology, Baskent University, Antalya, Turkey.

Transplantation Proceedings
|June 4, 2015
PubMed
Summary
This summary is machine-generated.

First-year hyperuricemia in kidney transplant recipients is linked to worse graft function and increased cardiovascular risks, including hypertension and arterial stiffness. This suggests hyperuricemia is a key indicator for both graft health and patient cardiovascular well-being.

More Related Videos

Mouse Model of Alloimmune-induced Vascular Rejection and Transplant Arteriosclerosis
07:05

Mouse Model of Alloimmune-induced Vascular Rejection and Transplant Arteriosclerosis

Published on: May 17, 2015

9.0K
Murine Kidney Transplant Technique
08:58

Murine Kidney Transplant Technique

Published on: October 20, 2015

17.6K

Related Experiment Videos

Last Updated: Apr 11, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

22.5K
Mouse Model of Alloimmune-induced Vascular Rejection and Transplant Arteriosclerosis
07:05

Mouse Model of Alloimmune-induced Vascular Rejection and Transplant Arteriosclerosis

Published on: May 17, 2015

9.0K
Murine Kidney Transplant Technique
08:58

Murine Kidney Transplant Technique

Published on: October 20, 2015

17.6K

Area of Science:

  • Nephrology
  • Cardiology
  • Endocrinology

Background:

  • Uric acid can negatively impact endothelial function and promote renal fibrosis.
  • Elevated uric acid levels post-kidney transplant may signify future complications.

Purpose of the Study:

  • To investigate the association between first-year hyperuricemia and subsequent graft dysfunction in kidney transplant recipients.
  • To determine the link between early hyperuricemia and the development of cardiovascular risk factors.

Main Methods:

  • Retrospective analysis of clinical and biochemical data from 100 kidney transplant recipients within the first post-transplantation year.
  • Evaluation of graft function and cardiovascular parameters including body composition, ambulatory blood pressure, and pulse wave velocity.
  • Hyperuricemia defined as uric acid ≥ 6.5 mg/dL on at least two consecutive tests.

Main Results:

  • 37% of recipients exhibited hyperuricemia one year post-transplant.
  • Hyperuricemic patients showed increased sagittal abdominal diameter, hip circumference, fat mass, and muscle mass.
  • Higher systolic blood pressure, pulse wave velocity, left ventricular mass index, and a faster decline in estimated glomerular filtration rate were observed in hyperuricemic individuals.

Conclusions:

  • Post-transplantation hyperuricemia is correlated with hypertension, arterial stiffness, and dyslipidemia.
  • Hyperuricemia serves as a marker for renal allograft dysfunction.
  • Hyperuricemia should be recognized as a significant cardiovascular risk factor in kidney transplant recipients.